Expired Canadian patentCanada
Gene expression markers for breast cancer prognosis
CA 2829477 C · Owner: Genomic Health, Inc. · Inventors: Cronin, Maureen T.; Baker, Joffre B.; Cobleigh, Melody A.
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides gene sets the expression of which is important in the diagnosis and/or prognosis of breast cancer.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 14, 2004 and granted July 10, 2018. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 14, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 14, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 14, 2004
GrantedJuly 10, 2018
Term endedJanuary 14, 2024
Patent numberCA 2829477 C
Classification (IPC)C12Q1/68 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.